The Net Margin of Cullinan Therapeutics Inc (CGEM) is -346.20%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -346.20% |
| 2023-12-31 | -346.20% |